trametinib
novartis
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'trametinib']
egfr re-challenge in crc , abs. 3520. ctdna-guided approach to overcome sec. resistance. orr 18% with pani in pts w/o acquired resistance mutations
but orr 0% with the addition of trametinib in pts with mutations
#crc #precisionmedicine 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine